1.
Mortato E, Paganini C, Talamonti M, Maffei V, Belcastro A, Di Raimondo C, et al. Real-world effectiveness and safety of lebrikizumab in adults with moderate-to-severe atopic dermatitis: a retrospective observational study with focus on head and neck involvement. Dermatol Reports [Internet]. 2026 Jul. 30 [cited 2026 Sep. 2];. Available from: https://journals.pagepress.net/dr/article/view/10460